|
|
|
|
Direct Cost |
Indirect Cost |
|
1F31CA165475-01A1 |
Elucidating the role of the epigenetic regulator USP22 in human cancer |
THOMAS JEFFERSON UNIVERSITY |
NCI |
$42,232 |
|
$42,232 |
1F31CA171672-01 |
GUCY2C targeted adoptive T cell therapy to treat metastatic colorectal cancer |
THOMAS JEFFERSON UNIVERSITY |
NCI |
$42,232 |
|
$42,232 |
1F31CA171680-01 |
Crosstalk between Desmogleins and Canonical Hedgehog Signaling |
THOMAS JEFFERSON UNIVERSITY |
NCI |
$42,232 |
|
$42,232 |
1F31CA174331-01 |
Identifying novel therapeutic strategies in mutant NRAS melanoma |
THOMAS JEFFERSON UNIVERSITY |
NCI |
$42,232 |
|
$42,232 |
1R01AI100561-01 |
Antigen stability as a parameter in rational T(CD8+)-targeting vaccine design |
THOMAS JEFFERSON UNIVERSITY |
NIAID |
$200,000 |
$110,000 |
$310,000 |
1R01CA157372-01A1 |
VPAC1 Recpetor-Targeted PET Imaging of Prostate Cancer |
THOMAS JEFFERSON UNIVERSITY |
NCI |
$412,644 |
$161,654 |
$574,298 |
1R01CA159945-01A1 |
SWI/SNF dysregulation in development and disease |
THOMAS JEFFERSON UNIVERSITY |
NCI |
$207,500 |
$114,125 |
$321,625 |
1R01CA160271-01A1 |
Anti-Migration Therapy for Prevention and Treatment of Breast Tumor |
THOMAS JEFFERSON UNIVERSITY |
NCI |
$207,500 |
$114,125 |
$321,625 |
1R01CA160495-01A1 |
FOXD3 up-regulation and ERBB3 signaling as an adaptive response to RAF inhibitors |
THOMAS JEFFERSON UNIVERSITY |
NCI |
$207,500 |
$114,125 |
$321,625 |
1R01CA163863-01A1 |
Impact of ErbB2 and RB Pathways on DCIS Progression and Treatment |
THOMAS JEFFERSON UNIVERSITY |
NCI |
$213,653 |
$117,509 |
$331,162 |
1R01CA164462-01 |
Progranulin signaling in bladder cancer |
THOMAS JEFFERSON UNIVERSITY |
NCI |
$207,500 |
$114,125 |
$321,625 |
1R01CA170533-01 |
GUCY2C hormone signaling at the intersection of obesity and colorectal cancer(PQ1 |
THOMAS JEFFERSON UNIVERSITY |
NCI |
$207,500 |
$114,125 |
$321,625 |
1R01DK096167-01 |
EGFR therapies for fatty liver surgery |
THOMAS JEFFERSON UNIVERSITY |
NIDDK |
$217,500 |
$119,625 |
$337,125 |
1R01GM100888-01A1 |
Multisubunit viral ATPases that couple ATP-hydrolysis to genome translocation |
THOMAS JEFFERSON UNIVERSITY |
NIGMS |
$190,000 |
$104,500 |
$294,500 |
1R01HL111541-01 |
Airway Inflammatory Pathways Regulating Glucocorticoid Receptor Phosphorylation |
THOMAS JEFFERSON UNIVERSITY |
NHLBI |
$253,200 |
$129,250 |
$382,450 |
1R01HL111621-01A1 |
Modeling Central Autonomic Regulatory Network Adaptation to Hypertension |
THOMAS JEFFERSON UNIVERSITY |
NHLBI |
$418,298 |
$212,928 |
$631,226 |
1R01NS073829-01A1 |
Study on Neurodegeneration Using TDP-43 Transgenic Rats |
THOMAS JEFFERSON UNIVERSITY |
NINDS |
$218,750 |
$105,875 |
$324,625 |
1R01NS075260-01A1 |
NSCs produce a triply effective cocktail in the CNS for MS/EAE therapy |
THOMAS JEFFERSON UNIVERSITY |
NINDS |
$196,875 |
$108,281 |
$305,156 |
1R01NS075839-01A1 |
Using reporter human iPS cells to study fate, function and Parkinson's disease |
THOMAS JEFFERSON UNIVERSITY |
NINDS |
$245,252 |
$134,889 |
$380,141 |
1R01NS079500-01 |
Protective Effect of Hemin Preconditioning after Intracerebral Hemorrhage |
THOMAS JEFFERSON UNIVERSITY |
NINDS |
$218,750 |
$120,313 |
$339,063 |